Purchase Order 75N91025P00244

Award Date 3/20/25
Potential Completion Date 3/19/26
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

The National Cancer Institute (NCI), a civilian federal agency, awarded a $12,075.00 firm fixed price purchase order contract to Eurofins Pharma Bioanalytics Services US, LLC, a foreign-owned for-profit organization, for laboratory analysis services. The contract has a period of performance ending on March 19, 2026 and was awarded on March 20, 2025. This contract does not have a set-aside designation.

Generated 3/7/25, 9:52 AM